ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.95
-0.40%
US Tech 100
17,253.60
-0.33%
S&P 500
5,102.49
-0.27%
US Dollar vs CAD
1.37458
0.57%
Bitcoin
61,281.31
-4.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) News

QTRX Quanterix Corporation

15.96
0.38 (2.44%)
Last Updated: 09:40:55
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Quanterix Corporation QTRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.38 2.44% 15.96 09:40:55
Open Price Low Price High Price Close Price Previous Close
15.47 15.32 15.995 15.58
more quote information »

Recent News

Date Time Source Heading
4/29/202415:00BWQuanterix To Report First Quarter 2024 Financial Results
3/21/202416:30BWQuanterix Outlines Partner Path With Labs to Expedite..
3/04/202416:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/04/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202408:00BWQuanterix Granted Breakthrough Device Designation from U.S...
2/29/202415:58EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202415:00BWQuanterix Releases Operating Results for Fourth Quarter and..
2/26/202417:58BWQuanterix Reschedules Q4 and Full Year 2023 Earnings..
2/26/202408:00BWQuanterix Announces First Collaborations with Five Health..
2/23/202415:30BWQuanterix to Present at Cowen’s 44th Annual Health Care..
2/16/202415:00BWQuanterix Fourth Quarter Earnings and Full Year 2023..
2/15/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202415:05EDGAR2Form 8-K - Current report
1/04/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202416:21EDGAR2Form 144 - Report of proposed sale of securities
12/12/202315:00BWQuanterix to Present at 42nd Annual J.P. Morgan Healthcare..
12/01/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202315:00BWQuanterix To Participate at The Canaccord Genuity MedTech,..
11/13/202306:00GLOBESotera Health Appoints Karen Flynn to Board of Directors
11/06/202316:56BWQuanterix Releases Operating Results for Third Quarter 2023
11/06/202316:03EDGAR2Form 8-K - Current report
11/06/202315:50BWQuanterix Releases Operating Results for Third Quarter 202
11/01/202308:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202315:00BWQuanterix to Report Third Quarter 2023 Financial Results on..
10/24/202315:30BWQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker..
10/23/202319:30BWQuanterix Announces New Agreement to Advance Blood Based..
10/02/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/28/202316:00BWQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease..
9/06/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202307:00BWQuanterix to Participate at the Morgan Stanley 21st Annual..
8/22/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202315:02EDGAR2Form 8-K - Current report
8/21/202315:30BWWilliam P. Donnelly Appointed to Quanterix’s Board of..
8/09/202307:52EDGAR2Form 8-K - Current report
8/09/202307:30BWQuanterix Appoints Vandana Sriram as Chief Financial Officer
8/08/202309:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:21EDGAR2Form 8-K - Current report
8/07/202316:13BWQuanterix Releases Operating Results for Second Quarter 2023
8/03/202307:00BWQuanterix to Present at Canaccord Genuity 43rd Annual Growth..
8/02/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/31/202307:00BWQuanterix’s Simoa® Technology Powers Large, International..
7/20/202307:00BWQuanterix to Report Second Quarter 2023 Financial Results on..
7/06/202316:37BWQuanterix Launches LucentAD Biomarker Blood Test to Aid..
7/05/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202315:00BWQuanterix to Participate in Fireside Chat at Goldman Sachs..

Your Recent History

NASDAQ
QTRX
Quanterix
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved